Literature DB >> 3667232

Cross-reactions between Mycoplasma hyopneumoniae and Mycoplasma flocculare--practical implications for the serodiagnosis of mycoplasmal pneumonia of swine.

C H Armstrong1, M J Freeman, L Sands-Freeman.   

Abstract

Previous studies using hyperimmune antisera revealed significant serologic cross-reactions between Mycoplasma hyopneumoniae and M. flocculare. These findings, coupled with observations that M. flocculare infection may be widespread, indicated that antibodies to M. flocculare might be common in swine sera and thus cause nonspecific reactions in serodiagnostic tests for mycoplasmal pneumonia of swine (MPS). Information reported here indicates that this premise may be invalid. Twenty-one swine were infected experimentally with M. flocculare. Sera were collected every 2 weeks and tested against M. flocculare and M. hyopneumoniae antigens in an enzyme-linked immunosorbent assay (ELISA). Immunoassays against M. flocculare revealed that swine were slow to seroconvert, and that seroconversion was characterized by low titers. Significantly, none of the sera reacted with M. hyopneumoniae. M. hyopneumoniae reference antisera, and sera from swine naturally infected with M. hyopneumoniae and M. flocculare were also evaluated by an antibody inhibition procedure, i.e., sera were mixed with M. hyopneumoniae or M. flocculare antigen, incubated overnight and tested against M. hyopneumoniae antigen in the ELISA. Treatment with M. hyopneumoniae antigen markedly reduced or abolished seroreactivity, whereas treatment with M. flocculare antigen had little effect. These findings suggest that swine infected with M. flocculare usually do not develop sufficient levels of antibodies to detract from the specificity of the ELISA used to diagnose MPS.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3667232

Source DB:  PubMed          Journal:  Isr J Med Sci        ISSN: 0021-2180


  7 in total

1.  Diagnosis and differentiation of Mycoplasma hyopneumoniae and Mycoplasma hyorhinis infections in pigs by PCR amplification of the p36 and p46 genes.

Authors:  J Caron; M Ouardani; S Dea
Journal:  J Clin Microbiol       Date:  2000-04       Impact factor: 5.948

2.  Species-specific monoclonal antibodies to Escherichia coli-expressed p36 cytosolic protein of Mycoplasma hyopneumoniae.

Authors:  J Caron; N Sawyer; B Ben Abdel Moumen; K Cheikh Saad Bouh; S Dea
Journal:  Clin Diagn Lab Immunol       Date:  2000-07

3.  Monoclonal antibodies to Escherichia coli-expressed P46 and P65 membranous proteins for specific immunodetection of Mycoplasma hyopneumoniae in lungs of infected pigs.

Authors:  K Cheikh Saad Bouh; F Shareck; S Dea
Journal:  Clin Diagn Lab Immunol       Date:  2003-05

4.  Sensitive and Specific Detection of Mycoplasma species by Consensus Polymerase Chain Reaction and Dot Blot Hybridization.

Authors:  Sunhwa Hong; Hyun-A Lee; Sang-Ho Park; Okjin Kim
Journal:  Lab Anim Res       Date:  2011-06-22

5.  Development of a blocking ELISA for detection of Mycoplasma hyopneumoniae infection based on a monoclonal antibody against protein P65.

Authors:  Maojun Liu; Gaimei DU; Yue Zhang; Yuzi Wu; Haiyan Wang; Bin Li; Yun Bai; Zhixin Feng; Qiyan Xiong; Fangfang Bai; Glenn F Browning; Guoqing Shao
Journal:  J Vet Med Sci       Date:  2016-04-14       Impact factor: 1.267

6.  Early detection and differential serodiagnosis of Mycoplasma hyorhinis and Mycoplasma hyosynoviae infections under experimental conditions.

Authors:  Luis G Giménez-Lirola; Henrique Meiroz-De-Souza-Almeida; Ronaldo L Magtoto; Aric J McDaniel; Maria M Merodio; Franco S Matias Ferreyra; Korakrit Poonsuk; Igor R H Gatto; David H Baum; Richard F Ross; Paulo H E Arruda; Kent J Schwartz; Jeffrey J Zimmerman; Rachel J Derscheid; Bailey L Arruda
Journal:  PLoS One       Date:  2019-10-07       Impact factor: 3.240

7.  Performance of Commercial Mycoplasma hyopneumoniae Serum Enzyme-Linked Immunosorbent Assays under Experimental and Field Conditions.

Authors:  Ana Paula S Poeta Silva; Ronaldo L Magtoto; Henrique M Souza Almeida; Aric McDaniel; Precy D Magtoto; Rachel J Derscheid; Maria M Merodio; Franco S Matias Ferreyra; Igor R H Gatto; David H Baum; Maria J Clavijo; Bailey L Arruda; Jeffrey J Zimmerman; Luis G Giménez-Lirola
Journal:  J Clin Microbiol       Date:  2020-11-18       Impact factor: 5.948

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.